Stryker (SYK) Tops Q2 EPS by 16c; Guides Higher

Stryker (NYSE: SYK) reported Q2 EPS of $2.54, $0.16 better than the analyst estimate of $2.38. Revenue for the quarter came in at $5 billion versus the consensus estimate of $4.83 billion.

GUIDANCE:

Stryker sees FY2023 EPS of $10.25-$10.45, versus the consensus of $10.16.

For earnings history and earnings-related data on Stryker (SYK) click here.

You May Also Be Interested In

• Wolfe Research Downgrades Stryker (SYK) to Peerperform
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c